Skip to content

Parkinson's genetics in Mexico show recurring signals and major evidence gaps

A systematic review found repeated genetic associations in Mexican studies, while differences in methods and limited ancestry analysis constrain what those signals mean.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The review found recurring links between Parkinson's disease and several genes in studies conducted in Mexico. It also highlighted genetic patterns associated with disease beginning earlier in life. These findings describe patterns across research samples; they do not establish causation or provide a reliable personal forecast of who will develop Parkinson's disease.

Keep in mind

This abstract-based synthesis reports substantial variation in study methods and limited analysis accounting for ancestry. It gives no pooled numerical risk estimates, so the size and precision of the highlighted associations cannot be assessed here.

What the review examined

Researchers examined studies of genetic variants and gene-expression profiles, checked study quality and aligned variant naming. Their goal was to organize evidence from a population underrepresented in global Parkinson's genetics research.

Patterns included an absent variant

A particular LRRK2 gene change, p.G2019S, was consistently absent in the reviewed studies. Some SNCA variants showed repeated associations, while certain PRKN changes featured in early-onset disease. These findings concern specific variants, not every change in those genes.

CHECK THE ORIGINAL

The original publication

The genetic architecture of Parkinson's disease in Mexico: a systematic review.

Arias-Carrión O, Romero-Gutiérrez E, Castellanos-Juárez FX et al.
Front Aging Neurosci · 2026

PubMed ID
41798285
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.